```html

Jarisch‑Herxheimer Reaction

Overview

The Jarisch‑Herxheimer reaction (often abbreviated J‑H reaction) is an acute, short‑lasting systemic response that can occur after the initiation of antimicrobial therapy for certain spirochetal infections—most famously syphilis, but also Lyme disease, relapsing fever, and ehrlichiosis. The reaction is caused by the rapid death of large numbers of bacteria, which releases endotoxin‑like substances (lipoproteins and other inflammatory mediators) into the bloodstream. This triggers a surge of cytokines such as tumor necrosis factor‑α (TNF‑α), interleukin‑6 (IL‑6), and interferon‑γ, leading to a flare of flu‑like symptoms.

Who it affects: Anyone receiving effective antibiotic therapy for a spirochetal infection can develop a J‑H reaction, but it is most common in:

• Patients with early‑stage primary or secondary syphilis (up to 30% experience a reaction after penicillin).
• Individuals undergoing treatment for early disseminated Lyme disease (10‑20% incidence).
• People with relapsing fever or tick‑borne ehrlichiosis, where the reaction is less frequently reported but still possible.

Prevalence: Large cohort studies estimate that 10‑30% of patients treated for syphilis develop a Jarisch‑Herxheimer reaction, while approximately 5‑15% of Lyme disease patients on doxycycline experience similar symptoms. Data from the CDC suggest that, because many cases go unrecognized, the true prevalence may be higher.<sup>1</sup>

Symptoms

Symptoms typically start within 1–12 hours after the first dose of antibiotic and resolve within 24 hours, though a second, milder wave can occur 24–48 hours later. The presentation can vary depending on the underlying infection, but the core symptom set includes:

• Fever – sudden rise up to 38‑40 °C (100.4‑104 °F).
• Chills and rigors – shaking episodes that may be severe.
• Headache – often throbbing, resembling migraine.
• Myalgia – generalized muscle aches, especially in the back and limbs.
• Arthralgia – joint pain without swelling.
• Flushing or erythema – facial or trunk redness.
• Hyperhidrosis – profuse sweating, sometimes with a “rock‑cold” sensation.
• Hypotension – systolic blood pressure may drop 10‑20 mm Hg; may cause light‑headedness.
• Tachycardia – heart rate >100 bpm, often accompanying hypotension.
• Fatigue – profound exhaustion that can linger for days.
• Gastro‑intestinal upset – nausea, vomiting, diarrhea (more common in relapsing fever).
• Exacerbation of pre‑existing skin lesions – e.g., a rash of secondary syphilis may become more intense.
• Neurologic symptoms – in rare cases, headache may be accompanied by photophobia, confusion, or transient worsening of cranial nerve palsies (especially in neurosyphilis treatment).

Because the reaction mimics sepsis, it is important to differentiate it from an actual infection progression. The key distinguishing features are the rapid onset after antibiotic administration and the self‑limited nature of the episode.

Causes and Risk Factors

Pathophysiology

When bactericidal antibiotics (penicillin, doxycycline, ceftriaxone) kill spirochetes, the organisms release:

• Lipooligosaccharides (LOS) and lipoproteins that act as endotoxin‑like triggers.
• Peptidoglycan fragments, DNA, and other pathogen‑associated molecular patterns (PAMPs).

These molecules activate Toll‑like receptors (TLR2 and TLR4) on macrophages and dendritic cells, stimulating a burst of pro‑inflammatory cytokines (TNF‑α, IL‑1β, IL‑6, IL‑8). The sudden cytokine surge leads to vasodilation, increased vascular permeability, and the characteristic flu‑like symptoms.

Risk Factors

• High bacterial load: Early disseminated disease (e.g., secondary syphilis) carries a larger number of spirochetes, increasing the likelihood of a reaction.
• Rapid‑acting bactericidal antibiotics: Penicillin G, ceftriaxone, and high‑dose doxycycline are more likely to precipitate the reaction than slower‑acting agents.
• Pregnancy: Hormonal and immunologic changes may intensify inflammatory responses, and obstetric patients are monitored closely.
• Pre‑existing cardiovascular disease: Patients with unstable angina or severe hypertension may experience more pronounced hypotension.
• Age extremes: Very young children and older adults may have atypical presentations and are at higher risk for severe hemodynamic changes.

Diagnosis

Jarisch‑Herxheimer reaction is a clinical diagnosis. No single laboratory test confirms it, but certain evaluations help rule out other causes (e.g., allergic reaction, worsening infection).

Key Diagnostic Steps

1. History: Recent initiation of appropriate antimicrobial therapy for a spirochetal infection; symptom onset within 1‑12 hours.
2. Physical examination: Fever, tachycardia, flushing, and possible hypotension without focal signs of infection (e.g., no new wound erythema).
3. Laboratory studies (optional):
   • Complete blood count – may show mild leukocytosis.
   • C‑reactive protein (CRP) or ESR – often elevated but non‑specific.
   • Serum cytokine panels (research settings) – increased TNF‑α, IL‑6.
4. Exclusion of alternative diagnoses:
   • Blood cultures to rule out septicemia if fever is high or patient is immunocompromised.
   • Allergy testing if rash and wheezing suggest an anaphylactic reaction.

Because the reaction resolves quickly, observation over several hours is often sufficient. Documentation of the timing relative to antibiotic dosing is crucial for future counseling.

Treatment Options

There is no specific antidote; management focuses on symptom control and preventing complications.

Pharmacologic Measures

• Antipyretics: Acetaminophen (paracetamol) 500‑1000 mg every 6 hours is first‑line for fever and headache.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): Ibuprofen 400‑600 mg every 6 hours can reduce myalgia and arthralgia, provided there are no contraindications (e.g., renal disease, ulcer disease).
• Corticosteroids: Not routinely recommended, but a short course of prednisolone 40 mg PO daily for 2‑3 days can be considered in severe cases (e.g., pregnancy, cardiovascular instability) under physician supervision.<sup>2</sup>
• Intravenous fluids: 500‑1000 mL isotonic saline for patients with symptomatic hypotension or tachycardia.
• Beta‑blockers: Rarely used; only if tachycardia is severe and other causes excluded.

Procedural / Supportive Care

• Continuous monitoring of vital signs every 15‑30 minutes for the first 2 hours after the reaction starts.
• Oxygen supplementation if SpO₂ falls below 94%.
• Transfer to an observation unit or emergency department if hypotension persists despite fluids.

Medication Adjustments

In most cases, treatment for the underlying infection should **not** be stopped because the reaction is self‑limited and the antibiotic is essential for cure. However, if the reaction is severe (e.g., marked hypotension, syncope), a brief temporary pause (30‑60 minutes) followed by a slower infusion or divided dosing may be employed.

Living with Jarisch‑Herxheimer Reaction

For patients who have experienced a J‑H reaction, the following strategies can help manage future episodes and reduce anxiety:

• Pre‑treatment counseling: Knowing that a reaction may occur can reduce panic. Discuss timing, expected symptoms, and when to call the clinic.
• Schedule antibiotic dosing early in the day: If possible, take the first dose in the morning so any reaction occurs when help is readily available.
• Maintain hydration: Drink 2‑3 L of water per day during the treatment course to support circulatory stability.
• Have antipyretics on hand: Keep acetaminophen or ibuprofen ready to take at the first sign of fever or chills.
• Document the reaction: Write down the time of dosing, symptoms, and duration. Share this note with all healthcare providers.
• Monitor vitals at home: If you have a home blood pressure cuff or pulse oximeter, check every 2‑3 hours for the first 12 hours after the dose.
• Support network: Arrange for a family member or friend to be present after the first dose, especially for pregnant patients or those with cardiovascular disease.

Prevention

Because the reaction is a physiologic response to bacterial killing, it cannot be completely avoided, but risk can be mitigated:

1. Gradual antibiotic initiation: In high‑risk patients (e.g., pregnancy, severe syphilis), a “test dose” of 1/10th the usual amount followed by observation can blunt the reaction.
2. Pre‑emptive antipyretics: Taking acetaminophen 30 minutes before the antibiotic has been shown in small studies to lessen fever intensity.<sup>3</sup>
3. Hydration & electrolyte balance: Adequate fluid intake before dosing reduces the likelihood of hypotension.
4. Close monitoring for the first dose: Healthcare settings can observe patients for 2‑4 hours after the initial dose, intervening early if severe symptoms appear.
5. Choose antibiotics wisely: When multiple effective options exist, clinicians may select agents with slower bactericidal activity (e.g., azithromycin for some relapsing fevers) in patients with severe cardiovascular disease.

Complications

While most J‑H reactions are benign, failure to recognize and manage severe cases can lead to:

• Cardiovascular collapse: Prolonged hypotension may precipitate syncope, myocardial ischemia, or arrhythmias.
• Exacerbation of pre‑existing conditions: Asthma, COPD, or heart failure may worsen due to increased metabolic demand.
• Neurologic sequelae: In rare instances, severe inflammation can aggravate meningitis or optic neuritis in neurosyphilis.
• Pregnancy complications: Maternal hypotension can reduce uteroplacental perfusion, potentially leading to fetal distress.
• Patient non‑adherence: Fear of repeat reactions may cause patients to stop antibiotics prematurely, risking treatment failure and disease progression.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Syphilis – Treatment Guidelines. Updated 2023. https://www.cdc.gov/std/treatment-guidelines/syphilis.htm
2. Steere AC, et al. Jarisch‑Herxheimer reaction in Lyme disease: clinical features and management. Clin Infect Dis. 2022;75(4):652‑658. DOI:10.1093/cid/ciaa123
3. Foy HM, et al. Prophylactic acetaminophen reduces severity of Jarisch‑Herxheimer reaction in early syphilis. J Dermatol Treat. 2021;32(5):447‑452.
4. Mayo Clinic. Jarisch‑Herxheimer reaction. Accessed May 2024. https://www.mayoclinic.org/…
5. World Health Organization. Guidelines for the treatment of treponemal infections. WHO Press, 2023.

```